- Shortage of skilled personnel
- Demographic change
- Increased pressure on margins and costs due to market changes and regulatory interventions
- High level of competition
- Challenges associated with digitalization
- Coronavirus pandemic impacting operations and data collection
PHOENIX Pharma SE
Greenhouse gas emissions & sustainability report data
In its 2020-02 to 2021-01 reporting, PHOENIX Pharma SE disclosed greenhouse gas emissions of 205.9K tCO2e. By scope: Scope 1: 50.2K tCO2e; Scope 2: 62.8K tCO2e; Scope 3: 92.9K tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
205.9K tCO2e
2020-02 to 2021-01
Waste
24.4K tons
2020-02 to 2021-01
📊 Emissions by Scope (2020-02 to 2021-01)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 50.2K tCO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 62.8K tCO2e |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 92.9K tCO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Reduced hazardous waste by 9.7%
- Reduced electricity consumption by 3.4%
- Reduced specific heating energy consumption by 7.8%
- Reduced specific natural gas consumption by 6.4%
- Optimized route planning, saving 750 tonnes of CO2 equivalents
- Increased the proportion of carrier bags made of recycled paper or plastic to 10.5%
🎯 Climate & Sustainability Targets
🔜 Short-term
- Sharpen focus on social commitment throughout the group by the end of 2021
🌱 ESG Focus Areas
Responsible company managementEnvironmental protectionSupporting employeesCommitment to society